The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene

Journal of Cellular Biochemistry

Volumn 110, Issue 1, 2010, Pages 1-9

  Jham, Bruno C ^a   Montaner, Silvia ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Akt; Endothelial cell; G protein coupled receptor; Human herpesvirus 8; Kaposi's sarcoma; Kaposi's sarcoma associated herpesvirus; mTOR; NF B; Paracrine neoplasia; PI3 kinase; Rac1; Rapamycin; Sirolimus; vGPCR

Indexed keywords

CHEMOKINE RECEPTOR; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B;

ANGIOGENESIS; AUTOCRINE EFFECT; CARCINOGENESIS; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; ONCOGENE ORF 74; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; VIRUS ONCOGENE;

GENES, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PARACRINE COMMUNICATION; RAC1 GTP-BINDING PROTEIN; RECEPTORS, G-PROTEIN-COUPLED; SARCOMA, KAPOSI; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 8;

EID: 77951736609     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22524     Document Type: Review

References (66)

1. Aoki M, Blazek E, Vogt PK. 2001. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci USA 98:136-141. (Pubitemid 32095876)
2. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350.
3. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, Gerhengorn MC. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89. (Pubitemid 28079220)
4. Bittner JJ. 1936. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84:162.
5. Bottero V, Sharma-Walia N, Kerur N, Paul AG, Sadagopan S, Cannon M, Chandran B. 2009. Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: A potential positive feedback loop for sustained ORF50 gene expression. Virology 392:34-351.
6. Bryan BA, D'Amore PA. 2007. What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci 64:2053-2065.
7. Butel JS. 2000. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21:405-426.
8. Campistol JM. 2009. Minimizing the risk of posttransplant malignancy. Transplantation 87:S19-22.
9. Cesarman E. 2002. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results Cancer Res 159:27-37.
10. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70:8218-8223. (Pubitemid 26339142)
11. Cesarman E, Mesri EA, Gershengorn MC. 2000. Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? J Exp Med 191:417-422.
12. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
13. Chin YR, Toker A. 2009. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 21:470-476.
14. Couty JP, Gershengorn MC. 2004. Insights into the viral G protein-coupled receptor encoded by human herpesvirus type 8 (HHV-8). Biol Cell 96:349-354.
15. Couty JP, Geras-Raaka E, Weksler BB, Gershengorn MC. 2001. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J Biol Chem 276:33805-33811. (Pubitemid 37384601)
16. DiMaio D, Mattoon D. 2001. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20:7866-7873. (Pubitemid 33135313)
17. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67:175-212; table of contents.
18. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546-4551. (Pubitemid 29190373)
19. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. 1998. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394:588-592. (Pubitemid 28366835)
20. Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G. 2003. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11:1457-1466. (Pubitemid 36776533)
21. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 1998. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12:502-513. (Pubitemid 28101013)
22. Guenova E, Metzler G, Hoetzenecker W, Berneburg M, Rocken M. 2008. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment. Arch Dermatol 144:692-693. (Pubitemid 351724445)
23. Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer. Cancer Cell 12:9-22.
24. Guo HG, Sadowska M, Reid W, Tschachler E, Hayward G, Reitz M. 2003. Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77:2631-2639. (Pubitemid 36222788)
25. Inoki K, Li Y, Xu T, Guan KL. 2003. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17:1829-1834. (Pubitemid 36944560)
26. Inoki K, Corradetti MN, Guan KL. 2005. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37:19-24. (Pubitemid 40070934)
27. Javier RT, Butel JS. 2008. The history of tumor virology. Cancer Res 68:7693-7706.
28. Jenner RG, Boshoff C. 2002. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 1602:1-22. (Pubitemid 34311897)
29. Jensen KK, Manfra DJ, Grisotto MG, Martin AP, Vassileva G, Kelley K, Schwartz TW, Lira SA. 2005. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol 174:3686-3694. (Pubitemid 40354079)
30. Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, el-Hashemite N, Onda H. 2002. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 11:525-534.
31. Lee DF, Hung MC. 2007. All roads lead to mTOR: Integrating inflammation and tumor angiogenesis. Cell Cycle 6:3011-3014.
32. Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. 2009. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci USA 106:8683-8688.
33. Mammoto A, Mammoto T, Ingber DE. 2008. Rho signaling and mechanical control of vascular development. Curr Opin Hematol 15:228-234. (Pubitemid 351507576)
34. Manning BD, Cantley LC. 2003. United at last: The tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans 31:573-578.
35. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340:1063-1070. (Pubitemid 29162510)
36. Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS. 2008. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27:1844-1852. (Pubitemid 351430813)
37. Merimsky O, Jiveliouk I, Sagi-Eisenberg R. 2008. Targeting mTOR in HIV-negative classic Kaposi's sarcoma. Sarcoma 2008:825093. (Pubitemid 351845452)
38. Montaner S. 2007. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: Emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Cell Cycle 6:438-443. (Pubitemid 46393447)
39. Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS. 2001. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61:2641-2648. (Pubitemid 32685850)
40. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind JS. 2003. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3:23-36. (Pubitemid 37443889)
41. Montaner S, Sodhi A, Servitja JM, Ramsdell AK, Barac A, Sawai ET, Gutkind JS. 2004. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104:2903-2911. (Pubitemid 39434978)
42. Montaner S, Sodhi A, Ramsdell AK, Martin D, Hu J, Sawai ET, Gutkind JS. 2006. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66:168-174. (Pubitemid 43166022)
43. Moore PS, Chang Y. 2001. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356:499-516. (Pubitemid 32442749)
44. Nador RG, Milligan LL, Flore O, Wang X, Arvanitakis L, Knowles DM, Cesarman E. 2001. Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology 287:62-70. (Pubitemid 32778239)
45. Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ. 1999. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104:687-695. (Pubitemid 29536354)
46. Ono M. 2008. Molecular links between tumor angiogenesis and inflammation: Inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99:1501-1506.
47. Pati S, Cavrois M, Guo HG, Foulke JS, Jr., Kim J, Feldman RA, Reitz M. 2001. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor OR F74: Evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75:8660-8673. (Pubitemid 32768970)
48. Pati S, Foulke JS, Jr., Barabitskaya O, Kim J, Nair BC, Hone D, Smart J, Feldman RA, Reitz M. 2003. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol 77:5759-5773. (Pubitemid 36538969)
49. Polson AG, Wang D, DeRisi J, Ganem D. 2002. Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. Cancer Res 62:4525-4530. (Pubitemid 34827318)
50. Richardson CJ, Schalm SS, Blenis J. 2004. PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol 15:147-159. (Pubitemid 38251643)
51. Rosenkilde MM, Schwartz TW. 2000. Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor. Mol Pharmacol 57:602-609.
52. Rous P. 1911. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13:397-399.
53. Schmitz R, Stanelle J, Hansmann ML, Kuppers R. 2009. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol 4:151-174.
54. Schwarz M, Murphy PM. 2001. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol 167:505-513. (Pubitemid 32567818)
55. Shope RE HE. 1933. Infectious papillomatosis of rabbits; with a note on the histopathology. J Exp Med 58:607-624.
56. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS. 2000. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor upregulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60:4873-4880.
57. Sodhi A, Montaner S, Gutkind JS. 2004a. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? Faseb J 18:422-427.
58. Sodhi A, Montaner S, Gutkind JS. 2004b. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5:998-1012. (Pubitemid 39611536)
59. Sodhi A, Montaner S, Patel V, Gomez-Roman JJ, Li Y, Sausville EA, Sawai ET, Gutkind JS. 2004c. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA 101:4821-4826.
60. Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET, Molinolo A, Gutkind JS, Montaner S. 2006. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10:133-143. (Pubitemid 44175903)
61. Stehelin D, Varmus HE, Bishop JM, Vogt PK. 1976. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260:170-173.
62. Tan W, Palmby TR, Gavard J, Amornphimoltham P, Zheng Y, Gutkind JS. 2008. An essential role for Rac1 in endothelial cell function and vascular development. Faseb J 22:1829-1838. (Pubitemid 351811460)
63. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. 2003. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13:1259-1268. (Pubitemid 36953298)
64. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, Lira SA. 2000. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191:445-454.
65. Yen-Moore A, Hudnall SD, Rady PL, Wagner RF, Jr., Moore TO, Memar O, Hughes TK, Tyring SK. 2000. Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS- associated and classic Kaposi's sarcoma: Potential role of HIV-1 Tat. Virology 267:247-251. (Pubitemid 30123607)
66. Yoshida M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19:475-496. (Pubitemid 32368043)